Get GLP-1 in Florida 2026: Telehealth from $129/mo

Q: Can telehealth prescribe GLP-1 in Florida?

Yes. Florida Statute 456.47 allows licensed clinicians to prescribe GLP-1 medications via telehealth, including both video and questionnaire-based evaluations. GLP-1 receptor agonists are not controlled substances under Florida or federal law, so the prescribing process is straightforward and PlexusDx Weight Management Protocols ship to all Florida zip codes via async intake.

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Florida residents have one of the most permissive telehealth environments in the country for GLP-1 weight management. Florida Statute §456.47 lets a licensed clinician establish the patient-provider relationship by video or written-questionnaire telehealth visit, GLP-1 medications are not controlled substances under Florida law, and the Sunshine State Board of Medicine sets the follow-up cadence (re-evaluation at least every three months). What that means in practice: if you're a Florida resident with a qualifying BMI, you can typically complete intake online, get a prescription routed, and have medication shipped to your door within days — without an in-person exam. The harder question is which path actually fits your wallet and your biology. This article walks the legal framework, the four real cost paths Florida patients use, and where the PlexusDx Microdose GLP-1 Protocol ($129/mo flat), Semaglutide Injection ($149/mo), and Tirzepatide Injection ($249/mo) sit relative to MEDVi, Ro, Hims/Hers, and your local Florida physician.

Is telehealth GLP-1 prescribing actually legal in Florida?

Yes. Florida Statute §456.47 governs telehealth practice across the state and authorizes licensed Florida clinicians (or out-of-state clinicians registered with the Florida Department of Health) to evaluate patients, establish a treatment relationship, and prescribe medications via synchronous video or asynchronous questionnaire-based telehealth. GLP-1 receptor agonists like semaglutide and tirzepatide are not scheduled controlled substances, so the additional DEA telemedicine prescribing rules that apply to controlled substances don't apply here. The Florida Board of Medicine's anti-obesity drug rule does require re-evaluation at least every three months for patients on chronic weight-management medications — most reputable telehealth providers, including PlexusDx, build that cadence into the protocol. That's the legal floor; what varies between providers is medication source, oversight depth, and total cost.

State availability: how PlexusDx serves Florida residents

PlexusDx Weight Management Protocols are available in all 50 states, including Florida, with no membership fee and no insurance involvement — flat cash-pay pricing across six prescription compounds and four mechanism classes. Florida is one of the 45 states where the standard async intake applies: you complete the online health questionnaire, a licensed clinician reviews your history, and the prescription is routed to a U.S. compounding pharmacy that ships compounded semaglutide or tirzepatide directly to your Florida address. (Five states require a scheduled live consultation rather than async intake; Florida is not one of them.) Whether you're in Miami, Tampa, Orlando, Jacksonville, Fort Lauderdale, St. Petersburg, Tallahassee, Sarasota, Naples, Gainesville, or Pensacola, the same protocol pricing applies — Microdose GLP-1 Protocol at $129/mo flat is the entry tier; Semaglutide Injection ($149/mo) and Tirzepatide Injection ($249/mo) are the weekly-injection tiers; GLP-Squared ($249/mo) is the dual-compound option for patients escalating beyond single-agent therapy.

The real cost of GLP-1 in Florida: four paths compared

Florida cash-pay GLP-1 falls into four pricing models. First, FDA-approved branded medication via membership telehealth — Ro charges $149/mo membership and routes prescriptions for Wegovy or Zepbound through a partner pharmacy at retail or NovoCare/Lilly Direct self-pay rates ($149/mo for the Wegovy oral pill program, ~$499/mo for Lilly Direct Zepbound vials, or $1,000+/mo at branded list price). Annualized, that's roughly $3,576–$13,788/year depending on which medication and pricing tier you land on. Second, FDA-approved branded via per-visit pharmacy — Walgreens Weight Management charges $49 per visit plus medication ($149-$289/mo Wegovy pill); no subscription, no concierge, but no insurance handling either. Third, compounded medication via all-inclusive telehealth — MEDVi advertises $179 month one then $299/mo for compounded semaglutide or tirzepatide vials, all-inclusive. Fourth, compounded medication via PlexusDx Weight Management Protocols — the Microdose GLP-1 Protocol at $129/mo flat ($1,548/year), Semaglutide Injection at $2,148–$2,748/year, Tirzepatide Injection at $2,748–$3,708/year, or GLP-Squared at $2,148–$3,900/year. PlexusDx is the cheapest entry tier among compounded telehealth providers in Florida and competitive with MEDVi at the higher dose tiers, with no membership layered on top.

FDA-approved vs compounded: what each Florida path dispenses

This distinction is the single most important thing to understand before choosing. Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Rybelsus, Trulicity, and Victoza are FDA-approved finished drug products — they passed the SUSTAIN, STEP, SURPASS, and SURMOUNT trials and carry FDA-labeled efficacy and safety data. Compounded semaglutide and tirzepatide are pharmacy-prepared versions of the same active ingredients, made under U.S. compounding regulations by licensed compounding pharmacies; they are not FDA-approved finished products. Ro Body's primary path dispenses the FDA-approved branded medications. MEDVi and PlexusDx Weight Management Protocols dispense compounded semaglutide and tirzepatide. The clinical-effectiveness conversation isn't really about the active ingredient — it's the same molecule. It's about FDA approval status of the finished product, supply consistency, and which regulatory framework governs your medication. Florida law allows both paths when prescribed by a licensed clinician and dispensed through a licensed pharmacy.

Insurance, Medicare, Medicaid, and HSA/FSA in Florida

Most commercial insurance plans in Florida do not cover GLP-1 medications for weight loss as of April 2026; Type 2 diabetes coverage for Ozempic or Mounjaro is more common but still subject to prior authorization and step therapy. Florida Medicaid coverage of GLP-1s for weight loss is extremely limited; some plans cover GLP-1s for Type 2 diabetes diagnosis but generally not for obesity alone. Medicare has historically excluded weight-loss drugs by statute, though the Medicare GLP-1 Bridge demonstration (announced for July 2026) is set to cover Wegovy and Zepbound for eligible Part D beneficiaries at a $50/month copay, with the longer-term BALANCE Model launching in Part D in January 2027. HSA and FSA reimbursement for cash-pay GLP-1 protocols typically requires a Letter of Medical Necessity from the prescribing clinician and varies by plan administrator. PlexusDx is cash-pay only — we do not bill insurance, do not run as a membership, and do not offer a concierge insurance-appeals service. If insurance coverage at a low copay is the dominant decision factor, Ro Body's insurance concierge is the better fit; if cash-pay total cost is the dominant factor, PlexusDx is competitive at every dose tier.

Why Florida residents should consider a genetic baseline before week one

GLP-1 response varies meaningfully across patients. Variants in GLP1R (the GLP-1 receptor itself), GIPR (the GIP receptor — particularly relevant for tirzepatide), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide. The Precision Peptide Genetic Test maps 48 genes and 57 variants across 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — so the prescribing clinician knows whether a faster-than-typical titration, a slower one, or a tirzepatide-first approach is more likely to fit your biology before week one. The test is $298 standalone or $99 as an add-on after your first month on any PlexusDx protocol. Neither MEDVi, Ro, nor Hims/Hers performs this step in Florida; all three start from a population-average titration schedule and adjust based on subjective tolerability over the first 8–12 weeks. PlexusDx anchors that same conversation to a measurable genetic baseline.

Safety, side effects, and the boxed warning Florida patients should know

All FDA-approved GLP-1 receptor agonists and GIP/GLP-1 dual agonists share a similar safety profile that applies to compounded versions as well. Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and headache — typically most pronounced during dose-escalation and improving with time at the same dose. Less common but documented risks include pancreatitis, gallbladder disease, and acute kidney injury (often dehydration-driven from prolonged GI side effects). Both semaglutide and tirzepatide carry a boxed warning for thyroid C-cell tumors based on rodent studies; the medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Florida's Board of Medicine rule requiring re-evaluation at least every three months exists in part to catch and manage these issues. Whichever path you choose, make sure your provider follows that cadence and is reachable when side effects appear.

Step-by-step: how to start a PlexusDx protocol from Florida

Step 1: confirm you likely qualify — PlexusDx Weight Management Protocols are appropriate for adults with a BMI ≥ 30, or BMI ≥ 27 with a weight-related comorbidity (Type 2 diabetes, hypertension, dyslipidemia, sleep apnea); the medical team makes the final clinical determination. Step 2: choose your protocol — Microdose GLP-1 Protocol ($129/mo flat) is the entry tier with capsule, troche, lozenge, or sublingual delivery; Semaglutide Injection ($149/mo) is the weekly-injection semaglutide path; Tirzepatide Injection ($249/mo) is the weekly dual-agonist path; GLP-Squared ($249/mo) is the dual-compound stack. Step 3: complete the online health intake — medical history, current medications, contraindications screen, weight goals. Step 4: clinician review and prescription — a U.S.-licensed clinician reviews your intake and either approves, requests additional information, or recommends an alternative. Step 5: medication ships to your Florida address from a licensed compounding pharmacy. Step 6: optional — add the Precision Peptide Genetic Test for $99 after your first month so titration decisions through month two and beyond are anchored to your variants rather than population averages. Florida-mandated re-evaluation occurs at least every three months.

Frequently asked questions

Can telehealth prescribe GLP-1 in Florida?

Yes. Florida Statute §456.47 allows licensed clinicians to prescribe GLP-1 medications via telehealth, including both video and questionnaire-based evaluations. GLP-1 receptor agonists are not controlled substances under Florida or federal law, so the prescribing process is straightforward and PlexusDx Weight Management Protocols ship to all Florida zip codes via async intake.

Do I need an in-person exam or lab work to get GLP-1 in Florida?

No in-person exam is required. A telehealth evaluation legally establishes the patient-provider relationship in Florida. Lab requirements vary by provider; the PlexusDx clinical team requests labs only when clinically indicated by your intake history, not as a universal prerequisite for the initial prescription.

What is the cheapest legitimate GLP-1 option for Florida residents?

Among compounded telehealth options shipping to Florida, the PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest entry price — below MEDVi ($179 month one, $299/mo ongoing) and below Walgreens or Ro on a total annual basis. Among FDA-approved branded options, the Wegovy pill program at $149/mo through NovoCare is currently the lowest cash-pay rate.

Does Florida Medicaid or Medicare cover GLP-1 for weight loss?

Florida Medicaid coverage for weight-loss GLP-1s is extremely limited; coverage is more common for Type 2 diabetes diagnoses. Medicare has historically excluded weight-loss drugs, though the Medicare GLP-1 Bridge demonstration is set to begin July 2026 with a $50/month copay for eligible Part D beneficiaries on Wegovy or Zepbound. Until then, cash-pay protocols like PlexusDx are the most accessible path for most Florida residents.

Is compounded semaglutide legal in Florida?

Yes, when prescribed by a licensed clinician and prepared by a licensed U.S. compounding pharmacy. The FDA removed semaglutide from the official shortage list in February 2025, which narrowed the conditions under which broad compounding can continue, and the FDA has warned about fraudulent or unapproved GLP-1 products. PlexusDx works with U.S.-licensed compounding pharmacies and is transparent about compounded vs FDA-approved finished-product status.

How does the PlexusDx Precision Peptide Genetic Test help Florida patients?

The Precision Peptide Genetic Test maps 48 genes and 57 variants — including GLP1R, GIPR rs1800437, FTO, MC4R, and TCF7L2 — that influence GLP-1 response, appetite regulation, and metabolic signaling. The clinician uses these variants to individualize titration before week one rather than starting from population averages. Pricing is $298 standalone or $99 as an add-on after your first month on any protocol.

How often do I need follow-up appointments under Florida law?

The Florida Board of Medicine's anti-obesity drug rule requires re-evaluation at least every three months for patients on chronic weight-management medications. PlexusDx Weight Management Protocols build follow-up touchpoints into the protocol cadence so you stay compliant with state oversight rules and your clinician can adjust dose, formulation, or protocol as your response data accumulates.

How to Get GLP-1 in Florida (2026): Legal Telehealth Paths from $129/mo | PlexusDx